To evaluate the significance of MDSCs on BC prognosis, we investigated the proportion of MDSCs (CD11b+CD33lowHLA-DR−CD3−) cells in BC patients (n = 113) and healthy donors (n = 20). The gene discussed is ITGAM; the disease is breast cancer.